Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Tigecycline”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT00081744
What this trial is testing

Study Comparing Tigecycline to Imipenem/Cilastatin in Complicated Intra-Abdominal Infections in Hospitalized Subjects

Who this might be right for
Gram-Positive Bacterial InfectionsCross Infection
Wyeth is now a wholly owned subsidiary of Pfizer 850
Large-scale testing (Phase 3)WithdrawnNCT00911573
What this trial is testing

Study Evaluating Tigecycline Versus Clindamycin Or Vancomycin On Complicated Skin And Skin Structure Infections Including Those Due To Methicillin-Resistant Staphylococcus Aureus (MRSA) In Pediatric Subjects

Who this might be right for
Skin DiseasesInfection
Wyeth is now a wholly owned subsidiary of Pfizer
Large-scale testing (Phase 3)Study completedNCT00228410
What this trial is testing

Study Comparing Tigecycline and Vancomycin With Aztreonam in Complicated Skin and Skin Structure Infections

Who this might be right for
Skin Diseases, Infectious
Wyeth is now a wholly owned subsidiary of Pfizer 503
Not applicableStudy completedNCT03034174
What this trial is testing

Pharmacokinetics of High-dose Tigecycline in Critically Ill Patients

Who this might be right for
Septic ShockAntibiotic Resistant InfectionCritical Illness
Medical University of Lublin 37
Not applicableStudy completedNCT01840319
What this trial is testing

Retrospective Transverse Observational Study Of Previous Study (Initial Protocol, B1811030)

Who this might be right for
Survival Status at Day 30 After the Last Intake
Pfizer 156
Large-scale testing (Phase 3)Study completedNCT00575094
What this trial is testing

Study Evaluating the Safety and Efficacy of Intravenous Tigecycline to Treat Hospitalized Japanese Subjects

Who this might be right for
Community-Acquired Infections
Wyeth is now a wholly owned subsidiary of Pfizer 9
Not applicableStudy completedNCT01072539
What this trial is testing

Study Evaluating The Safety And Effectiveness In Subjects With Tigecycline Treatment

Who this might be right for
Complicated Skin and Skin Structure InfectionsComplicated Intra-abdominal InfectionsCommunity-Acquired Bacterial Pneumonia
Pfizer 3,172
Not applicableStudy completedNCT00481962
What this trial is testing

Health Economic Assessment of Tygacil® in the Treatment of Secondary Peritonitis in Intensive Care Units (ICUs)

Who this might be right for
Peritonitis
Wyeth is now a wholly owned subsidiary of Pfizer 180
Not applicableUnknownNCT04937894
What this trial is testing

Antibiotic Therapy for Infectious Diseases

Who this might be right for
Infectious Disease
Shandong University 300
Not applicableUnknownNCT05698160
What this trial is testing

Biomarkers and Prediction of Tigecycline Induced Coagulation Dysfunction

Who this might be right for
Blood Coagulation Disorder
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School 200
Large-scale testing (Phase 3)Study completedNCT00366249
What this trial is testing

Study Evaluating the Safety and Efficacy of a Once-daily Dose of Tigecycline vs Ertapenem in Diabetic Foot Infections (DFI) With a Substudy in Patients With Diabetic Foot Infections Complicated by Osteomyelitis.

Who this might be right for
Bacterial InfectionsDiabetic FootOsteomyelitis
Wyeth is now a wholly owned subsidiary of Pfizer 1,061
Not applicableEnrolling By InvitationNCT06990126
What this trial is testing

The Efficacy and Adverse Reactions of Neotetracycline in the Treatment of GNB Infections

Who this might be right for
Clinical Efficacy and Safety
The First Affiliated Hospital with Nanjing Medical University 300
Early research (Phase 1)Study completedNCT00406237
What this trial is testing

Pharmacokinetic Study Of Tigecycline In Adult Subjects With Primary Biliary Cirrhosis

Who this might be right for
Liver Cirrhosis, Biliary
Wyeth is now a wholly owned subsidiary of Pfizer 8
Not applicableUnknownNCT02883036
What this trial is testing

Vitro Study of Tigecycline to Treat Chronic Myeloid Leukemia

Who this might be right for
Chronic Myeloid Leukemia
Nanfang Hospital, Southern Medical University 100
Not applicableUnknownNCT04724798
What this trial is testing

Population Pharmacokinetics of Tigecycline in Patients Treated With ECMO

Who this might be right for
Extracorporeal Membrane OxygenationPharmacokineticsTigecycline
Nanfang Hospital, Southern Medical University 10
Not applicableStudy completedNCT00488488
What this trial is testing

A Pharmacovigilance Evaluation And Assessment Of The Prescribing Practice For Tygacil In Usual Health Care Setting

Who this might be right for
Infection
Pfizer 1,028
Large-scale testing (Phase 3)WithdrawnNCT01602874
What this trial is testing

Study Evaluating Tigecycline Versus Ceftriaxone In Complicated Intra-Abdominal Infections & Community Acquired Pneumonia

Who this might be right for
Community Acquired Bacterial PneumoniaComplicated Intra-Abdominal Infection
Pfizer
Large-scale testing (Phase 3)Study completedNCT00081575
What this trial is testing

Study Comparing Tigecycline vs. Levofloxacin in Subjects Hospitalized With Community-Acquired Pneumonia

Who this might be right for
Community-Acquired InfectionsBacterial PneumoniaCross Infection
Wyeth is now a wholly owned subsidiary of Pfizer 434
Not applicableStudy completedNCT00488397
What this trial is testing

Tigecycline In-Vitro Surveillance Study In Taiwan

Who this might be right for
Community Acquired Infections
Wyeth is now a wholly owned subsidiary of Pfizer 7,902
Post-approval studies (Phase 4)Study completedNCT00488761
What this trial is testing

Study Evaluating the Safety and Efficacy of Tigecycline in Hospitalized Patients With cSSSI

Who this might be right for
Skin Diseases, Infectious
Wyeth is now a wholly owned subsidiary of Pfizer 50
Next Page